What Averhealth does

Averhealth (legal entity Avertest, LLC) is a privately held forensic drug-testing and substance-use monitoring company founded in 1995 as Global Drug Testing Services and headquartered in Glen Allen, Virginia. The company serves U.S. criminal justice programs — primarily drug courts, DUI courts, veterans treatment courts, probation and parole departments, and social service agencies — operating across more than 2,700 programs, 75+ Patient Care Centers in 30+ states, and 550,000+ active clients with approximately 600 employees (500 in field operations).

The core product is Aversys, a proprietary web-based platform that automates randomized test scheduling, paper-free requisitions, electronic chain-of-custody, daily client check-ins, and compliance reporting. It is paired with a CAP-FDT, CLIA, and DEA accredited central laboratory in St. Louis, Missouri, staffed by PhD-level toxicologists, performing immunoassay screening and LC-MS/MS confirmation testing for 1,500+ substances across urine, oral fluid, hair, and sweat specimens with next-business-day turnaround. Recent product additions include the April 2025 Rapid Report mobile app for on-site results and a February 2025 Xylazine immunoassay screen. The company operates three service tiers — Virtual, Co-located, and Standalone — that bundle lab testing, supplies, software, and (optionally) on-site Patient Care Technicians.

Averhealth generates revenue primarily through per-test transaction fees on lab services bundled into recurring service-level subscriptions priced by program volume, panel complexity, and specimen type. Go-to-market is direct enterprise field sales targeting courts and government agencies, reinforced by Platinum Sponsorship of NADCP and APPA membership, plus a multi-channel content engine (blog, Recovery Corner podcast, webinars, Averhealth Academy). Ownership includes private equity backing from Five Arrows (Rothschild & Co), which invested alongside five acquisitions in 2019 (TASC Drug Testing Services, American Court Services, ADAM, Aspenti Health, JAMS). Dominique Delagnes became CEO in 2024, succeeding Mark Johnson.

Name

Averhealth

Legal name

Avertest, LLC

Website

https://averhealth.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Averhealth is a privately held forensic drug-testing and substance-use monitoring company serving U.S. criminal justice programs — drug courts, probation departments, and social service agencies — through its proprietary Aversys software, CAP-FDT accredited central laboratory, and 75+ Patient Care Centers nationwide.

Ownership category

akta.pro rank

Product category

Forensic Drug Testing Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels) (HLAHAOAG)

Keywords

• Substance abuse testing
• Court drug testing
• Forensic toxicology laboratory
• Treatment court services
• Probation monitoring software

Headquarters

HQ city

Richmond

HQ country

United States

HQ region

North America

Offices13 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Drug Testing Services: Laboratory-based substance abuse testing services for criminal justice programs including urine, oral fluid, hair, and sweat specimen testing. Revenue generated through per-test pricing based on service level and testing panel complexity.
2. Total Test Logistics Services: Comprehensive service packages including Virtual, Co-located, and Standalone service levels. Includes collection supplies, priority overnight shipping, and access to Aversys software. Priced based on program volume and service level requirements.
3. Aversys Software Platform: Web-based software subscription for program management, client tracking, and reporting. Included with service packages but available as standalone access for qualified programs.
4. FAIR Financial Assistance Program: Financial Affordability in Recovery program providing reduced-cost testing for qualifying patients with household income at or below 400% of Federal Poverty Guidelines. Court-ordered programs ineligible.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Averhealth provides laboratory-based substance abuse testing services for criminal justice programs combined with its proprietary Aversys web-based software platform. The company offers total test logistics spanning specimen collection, laboratory analysis (LC-MS/MS confirmation and immunoassay screening for 1,500+ substances), electronic chain of custody, and results reporting, delivered through three service levels (Virtual, Co-located, Standalone) to courts, probation, and parole agencies.

Product overview

Averhealth offers a single-source, integrated product portfolio centered on its proprietary Aversys software platform. The core offering combines Aversys (web-based program management and reporting software) with accredited laboratory testing services and three service level tiers (Virtual, Co-located, and Standalone). Supporting products include the Rapid Report App (mobile application for on-site results), Averhealth Academy (training platform), and the FAIR Program (financial assistance). The Aversys platform serves as the central hub connecting all services, while laboratory confirmation is provided through LC-MS/MS methodology. Recent additions include the April 2025 Rapid Report App launch and Xylazine immunoassay screening.

Differentiator

Problem solved

Functional benefit

Brands

• Aversys: Proprietary web-based software platform for substance use disorder monitoring, client reporting, and daily workload management.
• Rapid Report
• FAIR

Products and services

• Aversys Software Platform Proprietary web-based software platform that automates drug testing workflows, manages caseloads, delivers test results, provides client reporting, supports randomized scheduling, daily engagement, paper-free requisitions, electronic chain of custody, and individualized treatment programs for criminal justice programs.
• Rapid Report App Mobile application that delivers rapid, on-site drug testing results in seconds without waiting for external lab confirmation. Streamlines result reporting and lab confirmation request workflows for field staff.
• Laboratory Testing Services CAP-FDT, CLIA, and DEA accredited laboratory in St. Louis, MO offering immunoassay screening and LC-MS/MS confirmation testing for 1,500+ substances across urine, oral fluid, hair, and sweat specimens with next business day results.
• Virtual Services Service level providing drug testing supplies and shipping materials with full Aversys software access, enabling programs to automate the drug testing process while managing their own collections. Best for programs with existing collection capabilities needing lab services and software.
• Co-located Services Service level including Virtual Services features plus Averhealth-trained Patient Care Technicians who provide on-site collection services within facilities provided by the program partner, functioning as an extension of the customer's team.
• Standalone Services Full-service collection model with co-located features conducted at Averhealth-owned Patient Care Centers where clients complete visits without program staff handling specimen collection. Operates 75+ Patient Care Centers across 30+ states.
• Xylazine Immunoassay Screening Immunoassay screening for Xylazine with 10 ng/mL cutoff, more closely aligned with seized drug concentrations. Results delivered next business day for rapid intervention.

Quantifiable outcome

• Results delivered next business day after specimen collection, a full day faster than most lab-based testing companies
• +3 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

Four partnerships are on record, tiered core, flagship and minor.

• LabbcoreTechnology or Integration · 1 March 2025Strategic laboratory partnership to improve instant cup drug testing process. Averhealth provides CAP-FDT accredited confirmation results to Labb's customer base. Labb's platform combined with Averhealth's lab capabilities provides faster, more reliable results with expanded panel options. James Ramsey, CEO of Labb, stated collaboration creates most flexible testing technology for workplace testing.
• National Association of Drug Court Professionals (NADCP)flagshipStrategic or Co-development PartnerPlatinum Sponsor of NADCP, the premiere organization driving research, awareness, programming, and funding for all Specialty Courts. Partnership includes Justice for Vets, National Center for DWI Courts, and National Drug Court Institute. Provides platform for industry leadership and thought leadership.
• American Probation and Parole Association (APPA)coreStrategic or Co-development PartnerProud Corporate Member representing community corrections organizations throughout the U.S. and Canada. Supports industry collaboration and professional development in criminal justice supervision.
• National Emerging Drug Trends ConferenceminorStrategic or Co-development PartnerConference highlighting national experts on emerging drugs in schools, specialty courts, and communities. Covers topics including fentanyl, synthetic drugs, cannabis trends, and drug trafficking interdiction.

Scale indicators9 records

Recent moves14 records

Expansion highlights5 records

Direct peers

• Cordant Health Solutions: Forensic drug-testing laboratory and pharmacy services provider focused on criminal justice, behavioral health, and pain management. Closest direct competitor in court-mandated toxicology with comparable CAP-FDT-style credentials and court-admissible testing.
• Millennium Health: Specialty clinical laboratory focused on urine drug testing and pharmacogenetic testing for substance use disorder treatment and pain management. Directly competes with Averhealth in LC-MS/MS confirmation testing for the criminal-justice and behavioral-health markets.
• Omega Laboratories: Specialized forensic and workplace drug-testing laboratory offering hair, urine, and oral fluid testing with rapid turnaround. Directly comparable specialty toxicology peer serving legal and employment markets.
• Clinical Reference Laboratory (CRL): Independent reference laboratory offering a wide range of clinical and forensic toxicology testing, including employer and legal drug testing. Comparable scale and customer overlap with Averhealth.
• USDTL (United States Drug Testing Laboratories): Specialty laboratory focused on drugs-of-abuse testing for criminal justice, family services, and workplace markets. Direct competitor with similar forensic toxicology capabilities and customer profile.

Broad incumbents

• Redwood Toxicology Laboratory (Alere/Abbott): Specialized toxicology laboratory (acquired by Alere, now part of Abbott) providing forensic and clinical drug testing with broad panel offerings. Competes with Averhealth in substance-use monitoring for courts and workplace.
• Quest Diagnostics: Largest U.S. clinical laboratory with substantial drug-testing services for employer, criminal-justice, and clinical markets. Overlaps with Averhealth in toxicology panels and forensic testing, with significantly broader scale and sales reach.
• Laboratory Corporation of America (Labcorp): Major clinical laboratory with comprehensive drug-testing services for employment, legal, and healthcare clients. Competes with Averhealth for criminal-justice and employer drug-testing contracts at national scale.

Emerging players

• Psychemedics Corporation: Hair-analysis drug-testing laboratory serving employers, courts, and schools. Niche player with overlapping specimen-type capabilities (hair) and shared criminal-justice customers.
• Labb: Workplace drug-testing technology company whose instant-cup platform Averhealth confirms via its St. Louis lab. Both technology partner and adjacent competitor in the employer testing space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/averhealthcare
• LinkedInlinkedin.com/company/2647781
• Xx.com/Averhealth

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Averhealth